Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential
Authors:
Open Access
- 9 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1573684
Abstract
Ulcerative colitis (UC), a chronic inflammatory bowel disease, is driven by dysregulated immune responses and persistent intestinal inflammation. Pyroptosis, a caspase/gasdermin-mediated inflammatory cell death that exacerbates mucosal damage through excessive cytokine release and epithelial barrier disruption. Although pyroptosis is considered to be a key mechanism in the pathogenesis of UC, the systematic assessment of the role of natural products in targeting the pyroptosis pathway remains a critical research gap. The purpose of this review is to investigate the regulatory effects of natural products on pyroptosis in UC and elucidate the mechanisms of action and potential therapeutic effects. Key findings highlight polyphenols (e.g., resveratrol), flavonoids (e.g., Quercetin), and terpenoids as promising agents that inhibit NLRP3 inflammasome activation, suppress gasdermin D cleavage, and restore barrier integrity, thereby reducing pro-inflammatory cytokine release in preclinical UC models. Current evidence shows enhanced efficacy and safety when these compounds are combined with standard therapies, but clinical translation requires overcoming three key barriers: limited human trial data, uncharacterized polypharmacology, and suboptimal pharmacokinetics needing formulation refinement. Future research should prioritize standardized animal-to-human translational models, mechanistic studies on synergistic pathways, and rigorous clinical validation to harness the full potential of natural products in pyroptosis-targeted UC therapies.Keywords
This publication has 197 references indexed in Scilit:
- Gut microbiota in health and disease: advances and future prospectsMedcomm, 2024
- Forsythia suspensa (Thunb.) Vahl extract ameliorates ulcerative colitis via inhibiting NLRP3 inflammasome activation through the TLR4/MyD88/NF‐κB pathwayImmunity, Inflammation and Disease, 2023
- Dandelion polysaccharide treatment protects against dextran sodium sulfate‐induced colitis by suppressing NF‐κB/NLRP3 inflammasome‐mediated inflammation and activating Nrf2 in mouse colonFood Science & Nutrition, 2023
- Ulcerative Colitis in AdultsJAMA, 2023
- Cinnamaldehyde Ameliorates Dextran Sulfate Sodium‐Induced Colitis in Mice by Modulating TLR4/NF‐κB Signaling Pathway and NLRP3 Inflammasome ActivationChemistry & Biodiversity, 2023
- Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP/NLRP3 pathway in ratsCell Biology International, 2022
- Betaine Ameliorates Acute Sever Ulcerative Colitis by Inhibiting Oxidative Stress Induced Inflammatory PyroptosisMolecular Nutrition & Food Research, 2022
- Trans‑10‑Hydroxy‑2‐Decenoic Acid Alleviates Dextran Sulfate Sodium‐Induced Colitis in Mice via Regulating the Inflammasome‐Mediated Pyroptotic Pathway and Enhancing Colonic Barrier FunctionMolecular Nutrition & Food Research, 2022
- Chlorogenic Acid Suppresses miR‐155 and Ameliorates Ulcerative Colitis through the NF‐κB/NLRP3 Inflammasome PathwayMolecular Nutrition & Food Research, 2020
- The protective effect of nigeglanine on dextran sulfate sodium‐induced experimental colitis in mice and Caco‐2 cellsJournal of Cellular Physiology, 2019